ADVERTISEMENT
Xience SBA Bifurcation Stent for Treating Distal Left Main Disease in NSTEMI Patient
Download a PDF of this article.
Abstract: A 74-year-old female diagnosed with a non-ST elevation myocardial infarction was referred to our coronary care unit for urgent coronary angiography. Angiography revealed severe distal left main stenosis and a chronic total occlusion of the left circumflex coronary artery in its distal portion. Percutaneous coronary intervention was performed via the right femoral artery approach with a 7 Fr arterial sheath and EBU 3.0 guiding catheter (Medtronic). The Xience SBA stent was used. This device provides a good alternative to avoid multistent techniques while preserving integrity of the side branch, which results in procedural success. This dedicated bifurcation device may also be associated with shorter-duration procedures, lower contrast usage, and a reduction in total fluoroscopy time. To our knowledge, this is the first publication of this side-branch access device for the treatment of left main coronary artery disease.
J INVASIVE CARDIOL 2013;25(2):106-107
Key words: left main coronary disease, contrast media usage, side-branch disease, non-ST elevation myocardial infarction
________________________________________________
Case Description
A 74-year-old female diagnosed with non-ST elevation myocardial infarction was admitted to our coronary care unit. She was subsequently triaged to urgent coronary angiography. Cardiac catheterization revealed severe distal left main coronary artery (LMCA) stenosis and a chronic total occlusion of the circumflex coronary artery (LCX) in its distal portion (Figure 1A). Coronary artery bypass grafting was considered, but the patient refused to undergo cardiac surgery.
She was considered a candidate for percutaneous coronary intervention of the LMCA via the right femoral artery approach with a 7 Fr arterial sheath and EBU 3.0 guiding catheter (Medtronic Vascular). Two BHW guidewires (Abbott) were used. Using a dual-wire technique, the first was placed in the left anterior descending (LAD) coronary artery and the other in the LCX. Predilatation of both coronary arteries with a 3.0 x 15 mm Trek balloon (Abbott) at 16 atm was performed (Figures 1B and 1C). Following predilation, we implanted a 3.0 x 2.5 x 18 mm Xience SBA stent (Abbott Vascular) at 16 atm and subsequently postdilated it with a 4.0 x 15 mm Durastar NC balloon (Cordis) at 20 atm.
A satisfactory angiographic result was obtained with excellent preservation of the LCX ostium (Figures 2A and 2B). Our decision to utilize the Xience SBA stent in this case was based on our previous device success treating patients with complex coronary bifurcation lesions. The Xience SBA may represent a good alternative in lesions of this type and may help to avoid multistent techniques while preserving integrity of the side branch. To our knowledge, this is the first publication of Xience SBA stent usage in the invasive treatment of distal left main lesion.1-4
References
- Rizik DG, Klag JM, Tenaglia A, et al. Evaluation of a bifurcation drug-eluting stent system versus provisional T-stenting in a perfused synthetic coronary artery model. J Interv Cardiol. 2009;22(6):537-546.
- Hermiller JB. Contemporary bifurcation treatment strategies: the role of currently available slotted tube stents. Rev Cardiovasc Med. 2010;11(Suppl 1):S17-S26.
- Gil RJ, Vassiliev D, Michałek A, et al. First-in-man study of paclitaxel-eluting stent BiOSS (Bifurcation Optimisation Stent System) dedicated for coronary bifurcation stenoses: three months results. Kardiol Pol. 2012;70(1):45-52.
- Brennan JM, Dai D, Patel MR, et al. Characteristics and long-term outcomes of percutaneous revascularization of unprotected left main coronary artery stenosis in the United States: a report from the National Cardiovascular Data Registry, 2004 to 2008. J Am Coll Cardiol. 2012;59(7):648-54. Erratum in: J Am Coll Cardiol. 2012;59(16):1493-1494.
_________________________________________
From the Pomeranian Cardiology Centers, Gdańsk, Poland.
Disclosure: The authors have completed and returned the ICMJE Form for Disclosure of Potential Conflicts of Interest. The authors report no conflicts of interest regarding the content herein.
Manuscript submitted April 30, 2012, provisional acceptance given May 1, 2012, final version accepted July 26, 2012.
Address for correspondence: Dr Witold Dubaniewicz, Pomeranian Cardiology Centers, Gdańsk, Pomorskie Centra Kardiologiczne, ul. Balewskiego 1, 83-200, Starogard Gdański, Poland. Email: wduban@gmail.com
